Skip to main content
Premium Trial:

Request an Annual Quote

Robert Radie, Luigi Grasso, Acolyte Biomedica, GeneCopoeia



Morphotek this week announced it has appointed Robert Radie as chief business officer and promoted Luigi Grasso to senior vice president of research & development.

Radie most recently served as senior vice president of strategic projects and planning at Vicuron Pharmaceuticals. Prior to that, Radie spent his professional career in a broad range of positions at Eli Lilly. He holds a BS in chemistry from Boston College.

Grasso co-founded Morphotek and has served as its vice president of research since its inception. He has a PhD in pathology from the University of Catania, Italy.



Acolyte Biomedica this week announced the launch of BacLite RapiTECT Mammalian for rapid enumeration of mammalian cells, extending the company's BacLite RapiTECT cell quantification and growth assay product line.

BacLite RapiTECT Mammalian uses adenylate kinase as a marker for viable cells. Acolyte said that the AK technology is up to 100 times more sensitive than standard ATP bioluminescence and up to 1 million times more sensitive than optical measurements.

GeneCopoeia this week announced the availability of OmicsLink ORF Lentiviral Expression Clones.

The lentiviral system is effective at delivering genetic material to whole-model organisms and almost all mammalian cells, including non-dividing cells, cells that are not active or growing, and difficult-to-transfect cells such as neurons, primary cells, and stem cells, GeneCopoeia said. More than 16,000 human genes have been cloned into three types of lentivrial expression vectors, GeneCopoeia said.


The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.